Overview
- 4 FDA inspections are on record.
- 4 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-07-24.
At a glance
Inspections
4
Form 483s
4
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 21 Jul 2025 – 24 Jul 2025 | Human Drugs | WL | View 483 → |
| 20 Jul 2020 – 24 Jul 2020 | Human Drugs | 483 | View 483 → |
| 3 Nov 2015 – 5 Nov 2015 | Human Drugs | 483 | View 483 → |
| 16 Dec 2013 – 18 Dec 2013 | Human Drugs | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
24 Jul 2025
21 CFR 212.20(e)
Written QA procedures established, followed
Cited by Khoa Nathan V Tran, Andrew Le, Gloria E Andia
24 Jul 2025
21 CFR 212.50
Adequate controls (general)
Cited by Khoa Nathan V Tran, Andrew Le, Gloria E Andia
24 Jul 2025
21 CFR 212.50(a)
Written control procedures
Cited by Khoa Nathan V Tran, Andrew Le, Gloria E Andia
24 Jul 2025
21 CFR 212.70(c)
Conform to specs prior to release
Cited by Khoa Nathan V Tran, Andrew Le, Gloria E Andia
Investigators
FDA investigators tied to this site in the record.
Anh Lac2 insp.
Khoa Nathan V Tran1 insp.
Andrew Le1 insp.
Gloria E Andia1 insp.
Linda F Murphy1 insp.
Scott N Lim1 insp.
David Eng1 insp.
Lance M De Souza1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 212.50 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 212.20(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.20(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.40(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.60(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.61(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.70(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 212.20(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 212.50(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 212.60(f) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 212.70(c) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind UCSF Radiopharmaceutical Facility's 4 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat